Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001184900.3(CARD8):āc.1385A>Gā(p.Gln462Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0237 in 1,614,094 control chromosomes in the GnomAD database, including 547 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
CARD8 (HGNC:17057): (caspase recruitment domain family member 8) The protein encoded by this gene belongs to the caspase recruitment domain (CARD)-containing family of proteins, which are involved in pathways leading to activation of caspases or nuclear factor kappa-B (NFKB). This protein may be a component of the inflammasome, a protein complex that plays a role in the activation of proinflammatory caspases. It is thought that this protein acts as an adaptor molecule that negatively regulates NFKB activation, CASP1-dependent IL1B secretion, and apoptosis. Polymorphisms in this gene may be associated with a susceptibility to rheumatoid arthritis. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2010]
Computational evidence support a benign effect (MetaRNN=0.0034770072).
BP6
Variant 19-48211939-T-C is Benign according to our data. Variant chr19-48211939-T-C is described in ClinVar as [Benign]. Clinvar id is 1169236.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-48211939-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0181 (2763/152278) while in subpopulation NFE AF= 0.0282 (1917/68018). AF 95% confidence interval is 0.0271. There are 26 homozygotes in gnomad4. There are 1326 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.